INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292 | -92.4% | 752 | -50.0% | 0.00% | – |
| Q2 2023 | $3,833 | +101.0% | 1,504 | +266.8% | 0.00% | – |
| Q1 2023 | $1,907 | +6475.9% | 410 | -93.5% | 0.00% | -100.0% |
| Q4 2022 | $29 | -99.9% | 6,263 | +19.0% | 0.00% | 0.0% |
| Q3 2022 | $25,000 | +127.3% | 5,263 | +128.8% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 2,300 | -18.1% | 0.00% | – |
| Q1 2022 | $14,000 | +366.7% | 2,810 | +451.0% | 0.00% | – |
| Q4 2021 | $3,000 | -57.1% | 510 | -46.9% | 0.00% | – |
| Q3 2021 | $7,000 | -94.3% | 960 | -92.7% | 0.00% | -100.0% |
| Q2 2021 | $122,000 | +577.8% | 13,118 | +581.1% | 0.00% | – |
| Q1 2021 | $18,000 | 0.0% | 1,926 | -5.4% | 0.00% | -100.0% |
| Q4 2020 | $18,000 | -71.9% | 2,035 | -62.8% | 0.00% | -75.0% |
| Q3 2020 | $64,000 | +30.6% | 5,476 | +253.3% | 0.00% | 0.0% |
| Q2 2020 | $49,000 | +1125.0% | 1,550 | +181.8% | 0.00% | – |
| Q1 2020 | $4,000 | +100.0% | 550 | -60.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 1,375 | +77.4% | 0.00% | – |
| Q1 2019 | $3,000 | -66.7% | 775 | -65.2% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | -47.1% | 2,225 | -25.2% | 0.00% | 0.0% |
| Q3 2018 | $17,000 | +54.5% | 2,975 | +8.2% | 0.00% | – |
| Q2 2018 | $11,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2018 | $11,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -35.3% | 2,750 | +1.9% | 0.00% | -100.0% |
| Q3 2017 | $17,000 | +88.9% | 2,698 | +135.0% | 0.00% | – |
| Q2 2017 | $9,000 | -10.0% | 1,148 | -25.8% | 0.00% | – |
| Q1 2017 | $10,000 | +11.1% | 1,548 | +19.3% | 0.00% | – |
| Q4 2016 | $9,000 | +12.5% | 1,298 | +44.2% | 0.00% | – |
| Q3 2016 | $8,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | +166.7% | 900 | +16.1% | 0.00% | – |
| Q1 2016 | $3,000 | +50.0% | 775 | +129.3% | 0.00% | – |
| Q4 2015 | $2,000 | – | 338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |